Categories: News

Hong Kong Tai Po Fire Draws Over HK$130 Million in Donations, AB DAO-Linked Foundation Leads with HK$15 Million Donation

HONG KONG, Dec. 4, 2025 /PRNewswire/ — Following the fire at Tai Po Hong Fuk Yuen in the New Territories on November 26, various sectors of society have provided donations to support the affected area. According to preliminary statistics, the total amount of pledged charitable donations has now exceeded HK$130 million. Among these contributions, the AB Charity Foundation, supported by AB DAO, has donated a cumulative total of HK$15 million through related organizations in three separate installments. Based on publicly available information, this is one of the highest known donations within the Web3 industry in response to this disaster.

- Advertisement -

The remaining funds have been contributed by numerous local enterprises, charitable organizations, and individuals. All donations are currently being coordinated and allocated by the relevant receiving agencies and will be utilized as planned for emergency livelihood assistance and subsequent resettlement of the affected residents.

- Advertisement -

 

- Advertisement -

View original content:https://www.prnewswire.com/in/news-releases/hong-kong-tai-po-fire-draws-over-hk130-million-in-donations-ab-dao-linked-foundation-leads-with-hk15-million-donation-302632533.html

- Advertisement -

Recent Posts

Deepak Group Goes Beyond Green with hands-On Mangrove Restoration

Deepak Group undertakes mangrove plantation drive on World Environment DaySustainable restoration along the Paniyadra coast,…

5 hours ago

Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (ADA) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study

•Translational data presented at ADA demonstrate icovamenib’s potential to promote muscle preservation and fat reduction,…

9 hours ago

Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026

Presentations will feature clinical results for ribupatide, a GLP-1/GIP receptor dual agonist being developed as…

9 hours ago

Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress

Clinical benefit, including remissions, demonstrated in both systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA)…

9 hours ago

Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules

June 05, 2026 20:13 ET  | Source: Bluejay Diagnostics, Inc. $8.5 million upfront with up…

9 hours ago